Synapse

← Eric D. Peterson

Papers by Eric D. Peterson

Page 4 · newest first

  1. Outcomes and Anticoagulation Use After Catheter Ablation for Atrial FibrillationCirculation Arrhythmia and Electrophysiology · 2019
  2. Machine Learning, Predictive Analytics, and Clinical PracticeJAMA · 2019
  3. Effects of Virtual Exercise Rehabilitation In-Home Therapy Compared with Traditional Care After Total Knee ArthroplastyJournal of Bone and Joint Surgery · 2019
  4. Association of a P2Y12 Inhibitor Copayment Reduction Intervention With Persistence and Adherence With Other Secondary Prevention MedicationsJAMA Cardiology · 2019
  5. A systematic review of randomized trials comparing double versus triple antithrombotic therapy in patients with atrial fibrillation undergoing percutaneous coronary interventionCatheterization and Cardiovascular Interventions · 2019
  6. Novel Oral Anticoagulant Based Versus Vitamin K Antagonist Based Double Therapy Among Stented Patients With Atrial FibrillationCirculation Cardiovascular Interventions · 2019
  7. Technology-Enabled Clinical TrialsCirculation · 2019
  8. Racial Differences in Elevated C‐Reactive Protein Among US Older AdultsJournal of the American Geriatrics Society · 2019
  9. Intensity of Lipid Lowering With Statin Therapy in Patients With Cerebrovascular Disease Versus Coronary Artery Disease: Insights from the PALM RegistryJournal of the American Heart Association · 2019
  10. Readmissions After Acute Myocardial Infarction: How Often Do Patients Return to the Discharging Hospital?Journal of the American Heart Association · 2019
  11. Thrombolytic therapy in older acute ischemic stroke patients with gastrointestinal malignancy or recent bleedingEuropean Stroke Journal · 2019
  12. Opportunities for improving use of evidence‐based therapy in patients with type 2 diabetes and cardiovascular diseaseClinical Cardiology · 2019
  13. Rivaroxaban versus warfarin treatment among morbidly obese patients with venous thromboembolism: Comparative effectiveness, safety, and costsThrombosis Research · 2019
  14. The Association Between Low‐Density Lipoprotein Cholesterol and Incident Atherosclerotic Cardiovascular Disease in Older Adults: Results From the National Institutes of Health Pooled CohortsJournal of the American Geriatrics Society · 2019
  15. Sex Differences in the Use of Statins in Community PracticeCirculation Cardiovascular Quality and Outcomes · 2019
  16. Intravenous Tissue Plasminogen Activator in Stroke MimicsCirculation Cardiovascular Quality and Outcomes · 2019
  17. Clinical Effectiveness of Direct Oral Anticoagulants vs Warfarin in Older Patients With Atrial Fibrillation and Ischemic StrokeJAMA Neurology · 2019
  18. Recent Myocardial Infarction is Associated With Increased Risk in Older Adults With Acute Ischemic Stroke Receiving Thrombolytic TherapyJournal of the American Heart Association · 2019
  19. Association Between Time to Treatment With Endovascular Reperfusion Therapy and Outcomes in Patients With Acute Ischemic Stroke Treated in Clinical PracticeJAMA · 2019
  20. Association Between Warfarin Control Metrics and Atrial Fibrillation Outcomes in the Outcomes Registry for Better Informed Treatment of Atrial FibrillationJAMA Cardiology · 2019
  21. The patient journey with proprotein convertase subtilisin/kexin type 9 inhibitors in community practiceJournal of clinical lipidology · 2019
  22. Comparative Effectiveness of β-Blocker Use Beyond 3 Years After Myocardial Infarction and Long-Term Outcomes Among Elderly PatientsCirculation Cardiovascular Quality and Outcomes · 2019
  23. Individual Patient-Level Data Sharing for Continuous Learning: A Strategy for Trial Data SharingNAM Perspectives · 2019
  24. Thrombolysis in young adults with strokeNeurology · 2019
  25. Safety of Dual‐Antiplatelet Therapy After Myocardial Infarction Among Patients With Chronic Kidney DiseaseJournal of the American Heart Association · 2019
  26. Effect of a Quality Improvement Intervention on Adherence to Therapies for Patients With Acute Ischemic Stroke and Transient Ischemic AttackJAMA Neurology · 2019
  27. Defining Clinically Important Difference in the Atrial Fibrillation Effect on Quality-of-Life ScoreCirculation Cardiovascular Quality and Outcomes · 2019
  28. Intravenous Tissue-Type Plasminogen Activator in Acute Ischemic Stroke Patients With History of Stroke Plus Diabetes MellitusStroke · 2019
  29. Effect of a Quality of Care Improvement Initiative in Patients With Acute Coronary Syndrome in Resource-Constrained Hospitals in ChinaJAMA Cardiology · 2019
  30. Trends in Readmissions and Length of Stay for Patients Hospitalized With Heart Failure in Canada and the United StatesJAMA Cardiology · 2019
  31. Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulantsJournal of Medical Economics · 2019
  32. Patient‐Reported Reasons for Declining or Discontinuing Statin Therapy: Insights From the PALM RegistrySHILAP Revista de lepidopterología · 2019
  33. Evaluation of Mortality Data From the Social Security Administration Death Master File for Clinical ResearchJAMA Cardiology · 2019
  34. Comparative effectiveness, safety, and costs of rivaroxaban and warfarin among morbidly obese patients with atrial fibrillationAmerican Heart Journal · 2019
  35. Association of International Normalized Ratio Stability and Bleeding Outcomes Among Atrial Fibrillation Patients Undergoing Percutaneous Coronary InterventionCirculation Cardiovascular Interventions · 2019
  36. Quantifying Importance of Major Risk Factors for Coronary Heart DiseaseCirculation · 2019
  37. Relationship Between Operator Volume and Long-Term Outcomes After Percutaneous Coronary InterventionCirculation · 2019
  38. Components and Trends in Door to Treatment Times for Endovascular Therapy in Get With The Guidelines-Stroke HospitalsCirculation · 2019
  39. Effect of Medication Co-payment Vouchers on P2Y₁₂ Inhibitor Use and Major Adverse Cardiovascular Events Among Patients With Myocardial InfarctionJAMA · 2019
  40. Ejection fraction, B‐type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failureClinical Cardiology · 2018
  41. Association of Renin-Angiotensin Inhibitor Treatment With Mortality and Heart Failure Readmission in Patients With Transcatheter Aortic Valve ReplacementJAMA · 2018
  42. Gait Speed and 1‐Year Mortality Following Cardiac Surgery: A Landmark Analysis From the Society of Thoracic Surgeons Adult Cardiac Surgery DatabaseJournal of the American Heart Association · 2018
  43. Evidence-Based Performance Measures and Outcomes in Patients With Acute Ischemic StrokeCirculation Cardiovascular Quality and Outcomes · 2018
  44. Association of Race/Ethnicity With Oral Anticoagulant Use in Patients With Atrial FibrillationJAMA Cardiology · 2018
  45. Influence of Cardiovascular Risk Communication Tools and Presentation Formats on Patient Perceptions and PreferencesJAMA Cardiology · 2018
  46. International Comparison of Patient Characteristics and Quality of Care for Ischemic Stroke: Analysis of the China National Stroke Registry and the American Heart Association Get With The Guidelines––Stroke ProgramJournal of the American Heart Association · 2018
  47. An international cluster-randomized quality improvement trial to increase the adherence to evidence-based therapies for acute ischemic stroke and transient ischemic attack patients: Rationale and design of the BRIDGE STROKE TrialAmerican Heart Journal · 2018
  48. Modeling the impact of real-world adherence to once-daily (QD) versus twice-daily (BID) non-vitamin K antagonist oral anticoagulants on stroke and major bleeding events among non-valvular atrial fibrillation patientsCurrent Medical Research and Opinion · 2018
  49. B-type natriuretic peptide, disease progression and clinical outcomes in atrial fibrillationHeart · 2018
  50. Pharmacotherapy for Atrial Fibrillation in Patients With Chronic Kidney Disease: Insights From ORBIT‐AFJournal of the American Heart Association · 2018